OmniAb (OABI) Selling, General & Administrative (2022 - 2026)
Powered by 
Analysis
OmniAb (OABI) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.21 Bn | 132.36 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.73 Bn | 58.55 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 57.59 Bn | 52.46 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 40.13 Bn | 35.04 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.55 Bn | 32.24 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.60 Bn | 27.77 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.70 Bn | 26.54 Bn | 358.27 Mn | 247.47 Mn |
| 10 | OmniAb | 582.80 Mn | 530.80 Mn | 12.81 Mn | 6.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.65 Mn |
| Mar 31, 2026 | 6.62 Mn |
| Dec 31, 2025 | 6.84 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 7.68 Mn |
| Mar 31, 2025 | 7.92 Mn |
| Dec 31, 2024 | 7.36 Mn |
| Sep 30, 2024 | 7.08 Mn |
| Jun 30, 2024 | 7.97 Mn |
| Mar 31, 2024 | 8.34 Mn |
| Dec 31, 2023 | 7.87 Mn |
| Sep 30, 2023 | 8.51 Mn |
| Jun 30, 2023 | 8.74 Mn |
| Mar 31, 2023 | 8.20 Mn |
| Dec 31, 2022 | 10.21 Mn |
| Sep 30, 2022 | 5.58 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 4.11 Mn |